A single-domain antibody detects and neutralises toxic Aß42 oligomers in the Alzheimer's disease CSF (2024)
Attributed to:
Probing Post-Translational Modification in Neurodegenerative Protein Aggregation with a Novel Antibody-Based Technology
funded by
UKRI FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13195-023-01361-z
PubMed Identifier: 38238842
Publication URI: http://europepmc.org/abstract/MED/38238842
Type: Journal Article/Review
Parent Publication: Alzheimer's Research & Therapy
Issue: 1